Literature DB >> 7199370

Prostaglandin E1 therapy for digital ulcers in scleroderma.

M Baron, G Skrinskas, M B Urowitz, P N Madras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7199370      PMCID： PMC1862816     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  24 in total

1.  Microcirculatory effects of prostaglandins E1, E2, and A1 in the rat mesentery and cremaster muscle.

Authors:  E J Messina; R Weiner; G Kaley
Journal:  Microvasc Res       Date:  1974-07       Impact factor: 3.514

2.  Femoral-artery infusion of prostaglandin E 1 in severe peripheral vascular disease.

Authors:  L A Carlson; I Eriksson
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

3.  Pulmonary vascular responses to prostaglandins and prostaglandin synthetase inhibitors in perinatal goats.

Authors:  S Cassin; T Tyler; C Leffler
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1978

4.  Intraarterial reserpine administration in Raynaud syndrome.

Authors:  I J McFadyen; E Housley; A I MacPherson
Journal:  Arch Intern Med       Date:  1973-10

5.  Healing of ischaemic ulcers by intravenous prostaglandin E1 in a woman with thrombangitis obliterans.

Authors:  A G Olsson; N Thyresson
Journal:  Acta Derm Venereol       Date:  1978       Impact factor: 4.437

6.  Intravenous prostaglandin E1 in severe peripheral vascular disease.

Authors:  L A Carlson; A G Olsson
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

7.  Effects of prostaglandin E1 and adrenaline on the pulmonary vascular resistance (PVR) in isolated rabbit lungs.

Authors:  A Hauge; P K Lunde; B A Waaler
Journal:  Life Sci       Date:  1967-04-01       Impact factor: 5.037

Review 8.  Prostaglandins, their intermediates and precursors: cardiovascular actions and regulatory roles in normal and abnormal circulatory systems.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Prog Cardiovasc Dis       Date:  1979 May-Jun       Impact factor: 8.194

9.  Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension.

Authors:  J Szczeklik; J S Dubiel; M Mysik; Z Pyzik; R Krol; T Horzela
Journal:  Br Heart J       Date:  1978-12

10.  Low molecular weight dextran infusions in systemic sclerosis with Raynaud's phenomenon: a report of nine cases.

Authors:  P Lane
Journal:  Br Med J       Date:  1970-12-12
View more
  3 in total

1.  Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma.

Authors:  J Keller; A Kaltenecker; K T Schricker; B Neidhardt; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

2.  Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis.

Authors:  M F Martin; J E Tooke
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-11

3.  Prostaglandin E1 vasospastic disease and thermography.

Authors:  V Kyle; G Parr; R Salisbury; P P Thomas; B Hazleman
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.